157 related articles for article (PubMed ID: 17900309)
41. Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.
Nagahara T; Okano J; Fujise Y; Abe R; Murawaki Y
Biomed Pharmacother; 2010 May; 64(5):319-26. PubMed ID: 20434301
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of liver carcinogenesis in Wistar rats by consumption of an aqueous extract from leaves of Ardisia compressa.
González de Mejía E; Ramírez-Mares MV; Arce-Popoca E; Wallig M; Villa-Treviño S
Food Chem Toxicol; 2004 Mar; 42(3):509-16. PubMed ID: 14871594
[TBL] [Abstract][Full Text] [Related]
43. beta-carotene inhibits persistent and stimulates remodeling gamma GT-positive preneoplastic lesions during early promotion of hepatocarcinogenesis.
Rizzi MB; Dagli ML; Jordão AA; Penteado MV; Moreno FS
Int J Vitam Nutr Res; 1997; 67(6):415-22. PubMed ID: 9433674
[TBL] [Abstract][Full Text] [Related]
44. Lanreotide for the treatment of acromegaly.
Castinetti F; Saveanu A; Morange I; Brue T
Adv Ther; 2009 Jun; 26(6):600-12. PubMed ID: 19533047
[TBL] [Abstract][Full Text] [Related]
45. Lutein presents suppressing but not blocking chemopreventive activity during diethylnitrosamine-induced hepatocarcinogenesis and this involves inhibition of DNA damage.
Moreno FS; Toledo LP; de Conti A; Heidor R; Jordão A; Vannucchi H; Cardozo MT; Ong TP
Chem Biol Interact; 2007 Jul; 168(3):221-8. PubMed ID: 17559825
[TBL] [Abstract][Full Text] [Related]
46. [In vivo apoptotic effect of alpha-2b interferon (IFN) on rat preneoplastic liver ].
Alvarez ML; Cerliani JP; Monti JA; Carnovale CE; Ronco T; Pellegrino JM; Pisani G; Lugano C; Carrillo MC
Medicina (B Aires); 2001; 61(5 Pt 2):666-9. PubMed ID: 12058585
[TBL] [Abstract][Full Text] [Related]
47. Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC).
Mitsogiannis IC; Skolarikos A; Deliveliotis C
Expert Opin Pharmacother; 2009 Feb; 10(3):493-501. PubMed ID: 19191684
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
[TBL] [Abstract][Full Text] [Related]
49. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
[TBL] [Abstract][Full Text] [Related]
50. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
51. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
de Conti A; Kuroiwa-Trzmielina J; Horst MA; Bassoli BK; Chagas CE; Purgatto E; Cavalher FP; Camargo AA; Jordão AA; Vannucchi H; Scolastici C; Ong TP; Moreno FS
J Nutr Biochem; 2012 Aug; 23(8):860-6. PubMed ID: 21940155
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats.
Ahmed HH; Khalil WK; Hamza AH
Toxicol Mech Methods; 2014 Dec; 24(8):593-602. PubMed ID: 25156538
[TBL] [Abstract][Full Text] [Related]
53. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H
J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718
[TBL] [Abstract][Full Text] [Related]
54. Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.
Fujise Y; Okano J; Nagahara T; Abe R; Imamoto R; Murawaki Y
Int J Oncol; 2012 Jun; 40(6):1779-88. PubMed ID: 22293778
[TBL] [Abstract][Full Text] [Related]
55. Effect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant.
El-Ashmawy NE; Khedr EG; El-Bahrawy HA; Abd El-Fattah EE
Nutr Cancer; 2016; 68(6):1044-51. PubMed ID: 27383944
[TBL] [Abstract][Full Text] [Related]
56. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
57. Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Caplin ME; Pavel M; Ćwikła JB; Phan AT; Raderer M; Sedláčková E; Cadiot G; Wolin EM; Capdevila J; Wall L; Rindi G; Langley A; Martinez S; Blumberg J; Ruszniewski P;
N Engl J Med; 2014 Jul; 371(3):224-33. PubMed ID: 25014687
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Hepatocarcinogenesis by ArtinM via Anti-proliferative and Pro-apoptotic Mechanisms.
Braz MM; Roque-Barreira MC; Ramalho FS; Oliveira CA; Augusto MJ; Ramalho LN
In Vivo; 2016 11-12; 30(6):845-852. PubMed ID: 27815471
[TBL] [Abstract][Full Text] [Related]
59. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs.
Imam H; Eriksson B; Lukinius A; Janson ET; Lindgren PG; Wilander E; Oberg K
Acta Oncol; 1997; 36(6):607-14. PubMed ID: 9408151
[TBL] [Abstract][Full Text] [Related]
60. Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients.
Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A
Prostate; 2001 May; 47(3):205-11. PubMed ID: 11351350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
